Align Technology (ALGN) Lowered to Equal Weight at Stephens

Align Technology (NASDAQ:ALGN) was downgraded by Stephens from an “overweight” rating to an “equal weight” rating in a research note issued to investors on Friday, MarketBeat Ratings reports. They presently have a $230.00 target price on the medical equipment provider’s stock. Stephens’ price target indicates a potential downside of 14.64% from the stock’s current price.

Several other research analysts have also recently issued reports on the stock. Deutsche Bank started coverage on shares of Align Technology in a report on Friday, December 8th. They issued a “hold” rating and a $250.00 target price on the stock. Morgan Stanley raised their target price on shares of Align Technology from $257.00 to $300.00 and gave the stock an “overweight” rating in a report on Monday, November 27th. Leerink Swann restated an “outperform” rating and issued a $250.00 target price on shares of Align Technology in a report on Friday, October 27th. Zacks Investment Research cut shares of Align Technology from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 27th. Finally, Credit Suisse Group raised their target price on shares of Align Technology from $175.00 to $209.00 and gave the stock an “outperform” rating in a report on Friday, October 27th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $236.23.

Shares of Align Technology (ALGN) traded down $1.24 during trading on Friday, hitting $269.46. 1,230,000 shares of the stock traded hands, compared to its average volume of 1,080,000. Align Technology has a 1 year low of $88.56 and a 1 year high of $273.60. The company has a market capitalization of $21,510.00, a PE ratio of 81.90, a price-to-earnings-growth ratio of 2.12 and a beta of 1.43.

Align Technology (NASDAQ:ALGN) last issued its earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.19. Align Technology had a net margin of 19.98% and a return on equity of 25.60%. The firm had revenue of $385.30 million for the quarter, compared to analysts’ expectations of $359.80 million. During the same quarter last year, the business earned $0.63 earnings per share. The business’s revenue was up 38.3% on a year-over-year basis. sell-side analysts predict that Align Technology will post 3.67 earnings per share for the current year.

In related news, Director Joseph Lacob sold 29,724 shares of the firm’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $260.91, for a total value of $7,755,288.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Emory Wright sold 5,025 shares of the firm’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $263.68, for a total value of $1,324,992.00. Following the completion of the sale, the vice president now directly owns 80,762 shares of the company’s stock, valued at approximately $21,295,324.16. The disclosure for this sale can be found here. Insiders sold 52,849 shares of company stock valued at $13,494,348 in the last ninety days. 1.60% of the stock is currently owned by insiders.

Institutional investors have recently made changes to their positions in the business. Schroder Investment Management Group purchased a new position in Align Technology during the second quarter valued at $104,000. Whittier Trust Co. purchased a new position in Align Technology during the third quarter valued at $107,000. BlueMountain Capital Management LLC purchased a new position in Align Technology during the second quarter valued at $148,000. Coldstream Capital Management Inc. purchased a new position in Align Technology during the second quarter valued at $202,000. Finally, Guardian Capital LP purchased a new position in Align Technology during the second quarter valued at $206,000. 82.95% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This story was posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2018/01/20/align-technology-algn-lowered-to-equal-weight-at-stephens.html.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Analyst Recommendations for Align Technology (NASDAQ:ALGN)

Leave a Reply